This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Chelsea Therapeutics, Inc.. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: The Innovative Contributions of Ingrid Hallin
Introduction
Ingrid Hallin is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 2 patents to her name, Hallin's work is recognized for its potential impact on healthcare.
Latest Patents
Hallin's latest patents focus on anthranilic acid derivatives. These compounds are characterized by specific formulas where X can be CH≡CH, CHO, or OCH, and Y can be hydrogen or a straight or branched C1-C6 alkyl. The compounds are designed to be useful in treating autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Additionally, pharmaceutical compositions containing these compounds, along with methods for their use and preparation, are also included in her patents.
Career Highlights
Ingrid Hallin is associated with Chelsea Therapeutics, Inc., where she continues to innovate in the pharmaceutical sector. Her work is instrumental in developing new therapeutic options for patients suffering from serious health conditions.
Collaborations
Hallin collaborates with notable colleagues, including Helén Tuvesson Andersson and Ulf Vellmar. Their combined expertise enhances the research and development efforts at Chelsea Therapeutics, Inc.
Conclusion
Ingrid Hallin's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to improving healthcare solutions. Her work continues to pave the way for advancements in the treatment of complex medical conditions.